Literature DB >> 13536492

Further experience with the lente insulins.

W M LANCASTER, I MURRAY.   

Abstract

Entities:  

Keywords:  INSULIN/therapeutic use

Mesh:

Substances:

Year:  1958        PMID: 13536492      PMCID: PMC2029058          DOI: 10.1136/bmj.1.5083.1331

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  Lente insulin in the treatment of diabetes mellitus.

Authors:  A MARBLE
Journal:  Med Clin North Am       Date:  1957-03       Impact factor: 5.456

2.  Insulin zinc suspension; four years' experience.

Authors:  M JERSILD
Journal:  Lancet       Date:  1956-11-17       Impact factor: 79.321

3.  Lente insulin; four years' experience.

Authors:  M E MORGANS; A G SPENCER
Journal:  Lancet       Date:  1956-11-17       Impact factor: 79.321

4.  Treatment of diabetes mellitus with insulin zinc suspension; a clinical study based on 479 cases.

Authors:  K J GURLING; J A ROBERTSON; H WHITTAKER; W OAKLEY; R D LAWRENCE
Journal:  Br Med J       Date:  1955-01-08

5.  Lente insulin (insulin zinc suspension): further studies.

Authors:  W OAKLEY
Journal:  Br Med J       Date:  1953-11-07

6.  The insulin-zinc suspensions.

Authors:  G R VENNING
Journal:  Lancet       Date:  1954-03-06       Impact factor: 79.321

7.  The new insulins-lente, ultralente, and semilente.

Authors:  I MURRAY; R B WILSON
Journal:  Br Med J       Date:  1953-11-07

8.  The insulin zinc suspensions.

Authors:  J D NABARRO; J M STOWERS
Journal:  Br Med J       Date:  1953-11-07

9.  A new long-acting insulin; a preliminary trial of lente Novo insulin.

Authors:  R D LAWRENCE; W OAKLEY
Journal:  Br Med J       Date:  1953-01-31
  9 in total
  1 in total

1.  INSULIN ZINC SUSPENSION AFTER TEN YEARS.

Authors:  I C FERGUSON; J BUCHANAN; I MURRAY
Journal:  Br Med J       Date:  1964-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.